Advertisement

Current Treatment Options in Allergy

, Volume 4, Issue 2, pp 283–285 | Cite as

Precision Medicine in Allergic Disorders

  • Cevdet Ozdemir
  • Mübeccel Akdis
  • Cezmi A. AkdisEmail author
INVITED COMMENTARY

The Era of Precision Medicine in Allergic Disorders

It is fully acknowledged in medical education that “There is no single disease as a general term that covers every patient, but there is individual characteristics and variations between patients and the treatment should focus on the individual patient not the disease.” This individual variability among patients has aroused the necessity for subcategorizations, tailoring, or customization of diseases. This concept has been brought up as “Ut quod ali cibus est aliis fuat acre venenum,” which means “What Is Food to One May Be Fierce Poison to Others”by Titus Lucretius Carus a Roman poet and philosopher for the description of food allergy (Wikipedia). Allergic patients have individual stories, different molecular mechanisms, different visible characteristics and disease outcomes under the influence of genetic background, and epigenetic control by micro- and macro-environment. Accordingly, the three keywords, endotype, phenotype, and...

Keywords

Allergy Component resolved diagnosis Precision medicine 

References and Recommended Reading

  1. 1.
    Bachert C, Akdis CA. Phenotypes and emerging endotypes of chronic rhinosinusitis. J Allergy Clin Immunol Pract. 2016;4(4):621–8. doi: 10.1016/j.jaip.2016.05.004.CrossRefPubMedGoogle Scholar
  2. 2.
    Muraro A, Lemanske RF Jr, Hellings PW, Akdis CA, Bieber T, Casale TB, et al. Precision medicine in patients with allergic diseases: airway diseases and atopic dermatitis-PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology. J Allergy Clin Immunol. 2016;137(5):1347–58. doi: 10.1016/j.jaci.2016.03.010.CrossRefPubMedGoogle Scholar
  3. 3.
    Berry A, Busse WW. Biomarkers in asthmatic patients: has their time come to direct treatment? J Allergy Clin Immunol. 2016;137(5):1317–24. doi: 10.1016/j.jaci.2016.03.009.CrossRefPubMedGoogle Scholar
  4. 4.
    Durham SR, Penagos M. Sublingual or subcutaneous immunotherapy for allergic rhinitis? J Allergy Clin Immunol. 2016;137(2):339–49 e10. doi: 10.1016/j.jaci.2015.12.1298.CrossRefPubMedGoogle Scholar
  5. 5.
    Werfel T, Allam JP, Biedermann T, Eyerich K, Gilles S, Guttman-Yassky E, et al. Cellular and molecular immunologic mechanisms in patients with atopic dermatitis. J Allergy Clin Immunol. 2016;138(2):336–49. doi: 10.1016/j.jaci.2016.06.010.CrossRefPubMedGoogle Scholar
  6. 6.
    Akdis CA, Ballas ZK. Precision medicine and precision health: building blocks to foster a revolutionary health care model. J Allergy Clin Immunol. 2016;137(5):1359–61. doi: 10.1016/j.jaci.2016.03.020.CrossRefPubMedGoogle Scholar
  7. 7.
    Galli SJ. Toward precision medicine and health: opportunities and challenges in allergic diseases. J Allergy Clin Immunol. 2016;137(5):1289–300. doi: 10.1016/j.jaci.2016.03.006.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Tomassen P, Vandeplas G, Van Zele T, Cardell LO, Arebro J, Olze H, et al. Inflammatory endotypes of chronic rhinosinusitis based on cluster analysis of biomarkers. J Allergy Clin Immunol. 2016;137(5):1449–56 e4. doi: 10.1016/j.jaci.2015.12.1324.CrossRefPubMedGoogle Scholar
  9. 9.
    Bachert C, Gevaert E. Advances in rhinitis and rhinosinusitis in 2015. J Allergy Clin Immunol. 2016;138(5):1277–83. doi: 10.1016/j.jaci.2016.09.008.CrossRefPubMedGoogle Scholar
  10. 10.
    Jutel M, Agache I, Bonini S, Burks AW, Calderon M, Canonica W, et al. International consensus on allergy immunotherapy. J Allergy Clin Immunol. 2015;136(3):556–68. doi: 10.1016/j.jaci.2015.04.047.CrossRefPubMedGoogle Scholar
  11. 11.
    Klimek L, Mosbech H, Zieglmayer P, Rehm D, Stage BS, Demoly P. SQ house dust mite (HDM) SLIT-tablet provides clinical improvement in HDM-induced allergic rhinitis. Expert Rev Clin Immunol. 2016;12(4):369–77. doi: 10.1586/1744666X.2016.1144473.CrossRefPubMedGoogle Scholar
  12. 12.
    Ozdemir C, Kucuksezer UC, Akdis M, Akdis CA. Mechanisms of aeroallergen immunotherapy: subcutaneous immunotherapy and Sublingual immunotherapy. Immunol Allergy Clin N Am. 2016;36(1):71–86. doi: 10.1016/j.iac.2015.08.003.CrossRefGoogle Scholar
  13. 13.
    Pepper AN, Calderon MA, Casale TB. Sublingual immunotherapy for the polyallergic patient. J Allergy Clin Immunol Pract. 2017;5(1):41–5. doi: 10.1016/j.jaip.2016.06.019.CrossRefPubMedGoogle Scholar
  14. 14.
    Virchow JC, Backer V, Kuna P, Prieto L, Nolte H, Villesen HH, et al. Efficacy of a house dust mite sublingual allergen immunotherapy tablet in adults with allergic asthma: a randomized clinical trial. JAMA. 2016;315(16):1715–25. doi: 10.1001/jama.2016.3964.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG 2017

Authors and Affiliations

  • Cevdet Ozdemir
    • 1
  • Mübeccel Akdis
    • 2
  • Cezmi A. Akdis
    • 2
    • 3
    Email author
  1. 1.Memorial Health Group, Department of Pediatric AllergyAtasehir HospitalIstanbulTurkey
  2. 2.Swiss Institute of Allergy and Asthma Research (SIAF), University of ZurichDavosSwitzerland
  3. 3.Christine Kühne-Center for Allergy Research and EducationDavosSwitzerland

Personalised recommendations